Bogart Wealth LLC’s Prometheus Biosciences, Inc. Common Stock RXDX Stock Holding History

Bogart Wealth LLC’s Portfolio RXDX Stock Details RXDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-7	Closed	-$751	–	1149
2023 Q1	$751	Buy	+7	New	+$806	﹤0.01%	1008

Other funds holding RXDX

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

FCA

FinTrust Capital Advisors Greenville, South Carolina $591M AUM 26.89% 1-Year Est. Return

Bogart Wealth LLC's RXDX Position: Q2 2023 in Review

Bogart Wealth LLC sold out of Prometheus Biosciences, Inc. Common Stock (RXDX) in Q2 2023, closing a stake of 7 shares — an estimated $751 sold.

Bogart Wealth LLC first reported a position in RXDX in Q1 2023 and held it in 1 quarter. The position peaked at $751 in Q1 2023. 2 funds tracked by Wall St. Rank hold RXDX as of Q2 2023.

Bogart Wealth LLC reported no remaining Prometheus Biosciences, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
Bogart Wealth LLC sold 7 Prometheus Biosciences, Inc. Common Stock shares in Q2 2023, an estimated $751.
Bogart Wealth LLC first reported a position in Prometheus Biosciences, Inc. Common Stock in Q1 2023 and held it in 1 quarter.
Bogart Wealth LLC's Prometheus Biosciences, Inc. Common Stock position peaked at $751 in Q1 2023.
2 funds tracked by Wall St. Rank held Prometheus Biosciences, Inc. Common Stock as of Q2 2023.

Based on Bogart Wealth LLC's 13F filing for Q2 2023, filed 31 Jul 2023.